Plasma adiponectin concentrations and correlates in African Americans in the Hypertension Genetic Epidemiology Network (HyperGEN) study

Metabolism: Clinical and Experimental

Volumn 56, Issue 8, 2007, Pages 1011-1016

  Shikany, James M ^a   Lewis, Cora E ^a   Freedman, Barry I ^b   Arnett, Donna K ^c   Leiendecker Foster, Catherine ^d   Jones, Tamekia L ^c   Redden, David T ^c   Oberman, Albert ^a  

^a University of Alabama at Birmingham   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GENETIC EPIDEMIOLOGY; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; MALE; PRIORITY JOURNAL;

ADIPONECTIN; ADULT; AFRICAN AMERICANS; ANALYSIS OF VARIANCE; BODY MASS INDEX; CHOLESTEROL, HDL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; INSULIN; LINEAR MODELS; MALE; SEX FACTORS; UNITED STATES;

EID: 34347371986     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.03.020     Document Type: Article

References (35)

1. Goldstein B.J., and Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89 (2004) 2563-2568
2. Holst D., and Grimaldi P.A. New factors in the regulation of adipose differentiation and metabolism. Curr Opin Lipidol 13 (2002) 241-245
3. Gil-Campos M., Canete R.R., and Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 23 (2004) 963-974
4. Weyer C., Funahashi T., Tanaka S., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
5. Cnop M., Havel P.J., Utzschneider K.M., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46 (2003) 459-469
6. Krakoff J., Funahashi T., Stehouwer C.D., et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 26 (2003) 1745-1751
7. Hotta K., Funahashi T., Arita Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
8. Yang W.S., Lee W.J., Funahashi T., et al. Weight reduction increases plasma levels of an adipose-derived, anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86 (2001) 3815-3819
9. Lindsay R.S., Funahashi T., Hanson R.L., et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360 (2002) 57-58
10. Matsuzawa Y., Funahashi T., Kihara S., et al. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24 (2004) 29-33
11. Stefan N., Vozarova B., Funahashi T., et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51 (2002) 1884-1888
12. Spranger J., Kroke A., Mohlig M., et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 361 (2003) 226-228 [erratum in: Lancet 361 (2002) 1060]
13. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
14. Mallamaci F., Zoccali C., Cuzzola F., et al. Adiponectin in essential hypertension. J Nephrol 15 (2002) 507-511
15. Matsubara M., Maruoka S., and Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87 (2002) 2764-2769
16. Ouchi N., Kihara S., Funahashi T., et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107 (2003) 671-674
17. Matsubara M., Namioka K., and Katayose S. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur J Endocrinol 148 (2003) 657-662
18. Pischon T., Girman C.J., Hotamisligil G.S., et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
19. Kazumi T., Kawaguchi A., Sakai K., et al. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 25 (2002) 971-976
20. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
21. Zoccali C., Mallamaci F., Tripepi G., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 134-141
22. Kern P.A., Di Gregorio G.B., Lu T., et al. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 52 (2003) 1779-1785
23. Duncan B.B., Schmidt M.I., Pankow J.S., et al. Adiponectin and the development of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes 53 (2004) 2473-2478
24. Steffes M.W., Gross M.D., Schreiner P.J., et al. Serum adiponectin in young adults-interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study. Ann Epidemiol 14 (2004) 492-498
25. Kanaya A.M., Fyr C.W., Vittinghoff E., et al. Serum adiponectin and coronary heart disease risk in older black and white Americans. J Clin Endocrinol Metab 91 (2006) 5044-5050
26. Williams R.R., Rao D.C., Ellison C., et al. NHLBI Family Blood Pressure Program: methodology and recruitment in the HyperGEN Network. Ann Epidemiol 10 (2000) 389-400
27. Phillips D.I., Clark P.M., Hales C.N., et al. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11 (1994) 286-292
28. Warnick G.R., Benderson J., and Albers J.J. Dextrab sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28 (1982) 1379-1388
29. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
30. David J.A., and Naito N.K. Separation of lipoprotein (Lp) fraction by the Beckman TL-100 table-top ultracentrifuge (UC). [abstract]. Clin Chem 32 (1986) 1094
31. Ouchi N., Kihara S., Arita Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
32. Fernandez-Real J.M., Castro A., Bazquez G., et al. Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care 27 (2004) 739-745
33. Motoshima H., Wu X., Sinha M.K., et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87 (2002) 5662-5667
34. Tan K.C., Xu A., Chow W.S., et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89 (2004) 765-769
35. Pajvani U.B., Hawkins M., Combs T.P., et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279 (2004) 12152-12162